DK173854B1 - 7alfa-Acylthio-9alfa,11alfa-epoxy-20-spirox-4-en-3,21-dioner, fremgangsmåde til deres fremstilling, farmaceutiske præparater med indhold deraf samt deres anvendelse til fremstilling af farmaceutiske præparater - Google Patents

7alfa-Acylthio-9alfa,11alfa-epoxy-20-spirox-4-en-3,21-dioner, fremgangsmåde til deres fremstilling, farmaceutiske præparater med indhold deraf samt deres anvendelse til fremstilling af farmaceutiske præparater Download PDF

Info

Publication number
DK173854B1
DK173854B1 DK198502800A DK280085A DK173854B1 DK 173854 B1 DK173854 B1 DK 173854B1 DK 198502800 A DK198502800 A DK 198502800A DK 280085 A DK280085 A DK 280085A DK 173854 B1 DK173854 B1 DK 173854B1
Authority
DK
Denmark
Prior art keywords
mixture
epoxy
solution
dione
acid
Prior art date
Application number
DK198502800A
Other languages
Danish (da)
English (en)
Other versions
DK280085D0 (da
DK280085A (da
Inventor
Michel Biollaz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of DK280085D0 publication Critical patent/DK280085D0/da
Publication of DK280085A publication Critical patent/DK280085A/da
Application granted granted Critical
Publication of DK173854B1 publication Critical patent/DK173854B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0083 membered carbocyclic rings in position 15/16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK198502800A 1984-06-21 1985-06-20 7alfa-Acylthio-9alfa,11alfa-epoxy-20-spirox-4-en-3,21-dioner, fremgangsmåde til deres fremstilling, farmaceutiske præparater med indhold deraf samt deres anvendelse til fremstilling af farmaceutiske præparater DK173854B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH300984 1984-06-21
CH300984 1984-06-21
CH464684 1984-09-28
CH464684 1984-09-28

Publications (3)

Publication Number Publication Date
DK280085D0 DK280085D0 (da) 1985-06-20
DK280085A DK280085A (da) 1985-12-22
DK173854B1 true DK173854B1 (da) 2001-12-27

Family

ID=25691934

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198502800A DK173854B1 (da) 1984-06-21 1985-06-20 7alfa-Acylthio-9alfa,11alfa-epoxy-20-spirox-4-en-3,21-dioner, fremgangsmåde til deres fremstilling, farmaceutiske præparater med indhold deraf samt deres anvendelse til fremstilling af farmaceutiske præparater

Country Status (16)

Country Link
US (1) US4670551A (es)
EP (1) EP0165902B1 (es)
AR (2) AR242036A1 (es)
AU (1) AU582754B2 (es)
CA (1) CA1239388A (es)
DE (1) DE3569540D1 (es)
DK (1) DK173854B1 (es)
ES (2) ES8704967A1 (es)
FI (1) FI83225C (es)
GR (1) GR851499B (es)
HU (1) HU192232B (es)
IE (1) IE58050B1 (es)
IL (1) IL75569A (es)
NO (1) NO165496C (es)
NZ (1) NZ212492A (es)
PT (1) PT80663B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69637140T2 (de) * 1995-12-11 2008-04-10 G.D. Searle Llc, Chicago Verfahren zur herstellung einer epoxy-verbindung
US6887991B1 (en) 1996-12-11 2005-05-03 G. D. Searle & Company Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
EP1223174A3 (en) * 1996-12-11 2005-03-16 G.D. Searle & Co. Processes for preparation of 3-keto-7alpha-alkoxycarbonyl-delta-4,5- steroids and intermediates useful therein
BR9714510A (pt) 1996-12-11 2000-11-28 Searle & Co Processo e preparo de esteróides de 9,11-époxi e intermediários úteis dos mesmos
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
MXPA04005674A (es) 2001-12-12 2004-10-15 Pharmacia Corp Metodo para tratar trastornos oftalmicos con antagonistas epoxi-esteroidales del receptor de aldosterona.
US7235655B2 (en) 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
WO2007025780A2 (en) * 2005-09-02 2007-03-08 Recordati Ireland Limited Aldosterone receptor antagonists
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3013012A (en) * 1960-12-22 1961-12-12 Searle & Co Alkanoylthio-17alpha-carboxyethyl-17beta-hydroxyandrosten-3-one lactones
US3095412A (en) * 1961-12-19 1963-06-25 Searle & Co 9alpha, 11alpha-epoxy and 11beta-chloro-9alpha-hydroxy 17alpha-(2-carboxyethyl)-17beta-hydroxyandrost-4-en-3-one gamma-lactones and delta1 and delta6 analogs
GB1041534A (en) * 1963-04-24 1966-09-07 Merck & Co Inc 20-spiroxane compounds
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US4559332A (en) * 1983-04-13 1985-12-17 Ciba Geigy Corporation 20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof
EP0134529B1 (de) * 1983-08-17 1990-03-21 Schering Aktiengesellschaft 7-alpha-Substituierte 3-Oxo-17alpha-pregn-4-en-21.17-carbolactone, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
AR245731A1 (es) 1994-02-28
EP0165902A2 (de) 1985-12-27
GR851499B (es) 1985-11-25
DE3569540D1 (en) 1989-05-24
DK280085D0 (da) 1985-06-20
IL75569A (en) 1989-03-31
US4670551A (en) 1987-06-02
HU192232B (en) 1987-05-28
NO852501L (no) 1985-12-23
ES557112A0 (es) 1987-08-16
NZ212492A (en) 1989-02-24
FI83225B (fi) 1991-02-28
NO165496B (no) 1990-11-12
PT80663A (en) 1985-07-01
FI83225C (fi) 1991-06-10
ES8704967A1 (es) 1987-04-16
IE851535L (en) 1985-12-21
ES8707737A1 (es) 1987-08-16
AR242036A1 (es) 1993-02-26
EP0165902B1 (de) 1989-04-19
ES544387A0 (es) 1987-04-16
IE58050B1 (en) 1993-06-16
CA1239388A (en) 1988-07-19
PT80663B (en) 1987-05-08
DK280085A (da) 1985-12-22
AU582754B2 (en) 1989-04-13
FI852430A0 (fi) 1985-06-19
HUT38367A (en) 1986-05-28
IL75569A0 (en) 1985-10-31
EP0165902A3 (en) 1986-10-22
FI852430L (fi) 1985-12-22
AU4397185A (en) 1986-01-02
NO165496C (no) 1991-02-20

Similar Documents

Publication Publication Date Title
DK173854B1 (da) 7alfa-Acylthio-9alfa,11alfa-epoxy-20-spirox-4-en-3,21-dioner, fremgangsmåde til deres fremstilling, farmaceutiske præparater med indhold deraf samt deres anvendelse til fremstilling af farmaceutiske præparater
EP0122232B1 (de) 20-Spiroxane und Analoge mit geöffnetem Ring E, Verfahren zu ihrer Herstellung, sowie pharmazeutische Präparate davon
CELLA et al. Steroidal aldosterone blockers. II1
JPH0242840B2 (es)
US4789668A (en) 1α,7α-dithio-substituted spirolactones, processes for their preparation, and their use as medicines
WO2007025780A2 (en) Aldosterone receptor antagonists
EP0644891B1 (en) Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
JPH0212480B2 (es)
US4331663A (en) 4α,5α-Epoxy-3,20-dioxopregnane-2α,16α-dicarbonitrile and intermediates and process for preparation, method of use and compositions thereof
Rosenheim et al. The metabolism of β-sitosterol
JPS59205400A (ja) 20−スピロキサン系ステロイド及びその製造方法並びに該ステロイドを含有する医薬
US3294822A (en) 3-unsubstituted delta4, 9(10)-19-norsteroids and process for their manufacture
SU1079177A3 (ru) Способ получени производных стероидспирооксатиазолидинов в виде их стереоизомеров или их смесей или их солей
DE3344057A1 (de) Eine neue lactonverbindung und pharmazeutische zusammensetzungen davon, sowie verfahren zu ihrer herstellung
Shaw et al. Steroidal Thiazenones and Related Compounds1
US3591583A (en) Steroidal lactones
Johns 3-Deoxy-16-haloestra-1, 3, 5 (10)-trienes
BE859336A (fr) Procede de preparation de nouveaux composes steroidiques ayant une fonction oxygene en position 19
CZ583989A3 (cs) Deriváty 5-methyl-19-nor-5Beta-pregn-9-enu a způsobjejich přípravy
JPS5874659A (ja) アミノシクロペンタン,その製法及び薬学的組成物

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK